#National Cancer Institute

SPORE grants have become the cornerstone of NCI’s efforts to advance collaborative, interdisciplinary translational cancer research.

Scientists emphasize using data and analyses from completed and ongoing trials to gain a better understanding of patient outcomes.

Forty-five percent of 182 phase 3 clinical trials between 1980 and 2017 influenced guideline care or new drug approvals.

The study tested the effectiveness of CEASE, a program that aims to reduce children’s exposure to secondhand smoke by helping parents quit.

Funding will help enroll more minority and underserved patients in cancer clinical trials across Louisiana and Mississippi.

A new study suggests that, for people with pancreatic cancer, the makeup of the bacteria in their tumors could predict how long they live.

The researchers found that very few women reported discussing costs with their medical team, despite their desire to do so.

I’d like to invite the cancer community to consider what you will do to facilitate data-sharing for the benefit of children with cancer.

An overactive immune system is the main reason that many people with both cancer and autoimmune diseases aren’t included in clinical trials.

“Don’t eat me” proteins are “like invisibility cloaks for the cancer,” preventing white blood cells from detecting and devouring tum...

New results confirm that the drug, Balversa (erdafitinib), can benefit people whose tumors have a certain genetic alteration.

How true is his statement? These facts add context.

Race-related differences in risk and smoking behaviors aren’t accounted for in current lung cancer screening recommendations.

New research suggests that inducing necroptosis in or around tumor cells can help the immune system rid the body of cancer cells.

The Cytophone device was able to detect a single cancer cell in a liter of blood.

The study’s findings open a window for very early detection of the disease and could help identify those who need more aggressive treatment.